LOS GATOS, Calif., Sept. 28, 2026 /PRNewswire/ -- Tulavi Therapeutics has been awarded a national group purchasing agreement and Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc. Effective September 15, 2026, the new agreement allows Premier members, at…